Basics |
Company: |
Pacific Biosciences of California, Inc. |
IPO Date: |
October 27, 2010 |
Sector: |
Healthcare |
Industry: |
Medical Diagnostics and Research |
Market Cap: |
$421.75M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.25 | 3.19%
|
Avg Daily Range (30 D): |
$0.09 | 5.29%
|
Avg Daily Range (90 D): |
$0.10 | 5.10%
|
Institutional Daily Volume |
Avg Daily Volume: |
2.37M |
Avg Daily Volume (30 D): |
12.76M |
Avg Daily Volume (90 D): |
10.31M |
Trade Size |
Avg Trade Size (Sh.): |
177 |
Avg Trade Size (Sh.) (30 D): |
511 |
Avg Trade Size (Sh.) (90 D): |
449 |
Institutional Trades |
Total Inst.Trades: |
4,256 |
Avg Inst. Trade: |
$2.2M |
Avg Inst. Trade (30 D): |
$1.07M |
Avg Inst. Trade (90 D): |
$1.16M |
Avg Inst. Trade Volume: |
.22M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.45M |
Avg Closing Trade (30 D): |
$.78M |
Avg Closing Trade (90 D): |
$.92M |
Avg Closing Volume: |
330.6K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.46
|
$-.22
|
$-.64
|
Diluted EPS
|
$-1.46
|
$-.22
|
$-.64
|
Revenue
|
$ 173.15M
|
$ 39.97M
|
$ 36.01M
|
Gross Profit
|
$ 36.8M
|
$ 10M
|
$ 5.94M
|
Net Income / Loss
|
$ -394.24M
|
$ -60.73M
|
$ -173.32M
|
Operating Income / Loss
|
$ -408.83M
|
$ -64.08M
|
$ -175.85M
|
Cost of Revenue
|
$ 136.35M
|
$ 29.96M
|
$ 30.08M
|
Net Cash Flow
|
$ -308.17M
|
$ -21.59M
|
$ 22.42M
|
PE Ratio
|
|
|
|
|